You have 9 free searches left this month | for more free features.

Food Effect

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Trial in Overland Park (TP-05 (lotilaner oral), fasted group, TP-05 (lotilaner oral), high-fat group, TP-05 (lotilaner

Active, not recruiting
  • Healthy
  • TP-05 (lotilaner oral), fasted group
  • +2 more
  • Overland Park, Kansas
    Dr. Vince Clinical Research
Feb 14, 2023

Healthy Volunteers Trial in Zibo (HSK31858, tablet, Placebo, tablet)

Completed
  • Healthy Volunteers
  • HSK31858, tablet
  • Placebo, tablet
  • Zibo, Shang Dong, China
    PKUCare Luzhong Hospital
Dec 15, 2022

Type 2 Diabetes Trial in Daejeon (CT-L01 12.5/1,000 mg)

Completed
  • Healthy
  • CT-L01 12.5/1,000 mg
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Jan 10, 2023

Acute Myeloid Leukemia in Children Trial (Clifutinib with fed state, Clifutinib with fasted state)

Not yet recruiting
  • Acute Myeloid Leukemia in Children
  • Clifutinib with fed state
  • Clifutinib with fasted state
  • (no location specified)
Jul 7, 2022

COPD, Respiratory Disease, Lower Respiratory Disease Trial in Miami (Vapendavir)

Enrolling by invitation
  • COPD
  • +4 more
  • Miami, Florida
    Syneos Health Miami
Jul 18, 2023

Healthy Participants Trial in Lincoln (AB521)

Recruiting
  • Healthy Participants
  • Lincoln, Nebraska
    Celerion, Inc.
Aug 22, 2023

Ovarian Cancer Trial in Turku (KAND145, Placebo)

Not yet recruiting
  • Ovarian Cancer
  • Turku, Finland
    Clinical Research Services Turku - CRST Oy
Sep 26, 2023

MDD (MDD) Trial in Ahmedabad (Vortioxetine Hemihydrobromide Orally Disintegrating Tablets)

Active, not recruiting
  • Major Depressive Disorder (MDD)
  • Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
  • Ahmedabad, Gujarat, India
    Cliantha Research Limited
Oct 24, 2022

Schizophrenia Trial in Saga-shi (OPC-34712FUM/ Brexpiprazole fumarate)

Recruiting
  • Schizophrenia
  • OPC-34712FUM/ Brexpiprazole fumarate
  • Saga-shi, Japan
    Rainbow & Sea Hospital
Sep 6, 2023

Autoimmune Diseases Trial in Merthyr Tydfil (AX-158)

Active, not recruiting
  • Autoimmune Diseases
  • Merthyr Tydfil, United Kingdom
    Simbec-Orion
Dec 19, 2022

Inflammatory Bowel Disease Trial in Nedlands (HRS-7085 tablets, Placebo tablet)

Recruiting
  • Inflammatory Bowel Disease
  • HRS-7085 tablets
  • Placebo tablet
  • Nedlands, Western Australia, Australia
    Linear Clinical Research
Dec 19, 2022

Food Effect Trial in Tempe (VS-6766)

Completed
  • Food Effect
  • Tempe, Arizona
    Celerion
May 6, 2022

Helicobacter Pylori Infection Trial in Changchun (TNP-2198, TNP-2198 Placebo)

Completed
  • Helicobacter Pylori Infection
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Oct 7, 2023

Pain Trial in Salt Lake City (VX-548)

Recruiting
  • Pain
  • Salt Lake City, Utah
    ICON Salt Lake City
Aug 4, 2022

Healthy Adult Participants Trial in Baltimore (Treatment A, Treatment B, Treatment C)

Completed
  • Healthy Adult Participants
  • Treatment A
  • +2 more
  • Baltimore, Maryland
    Baltimore Parexel EPCU
Jan 19, 2023

Healthy Adult Subjects Trial in Tokyo (MT-1186)

Completed
  • Healthy Adult Subjects
  • Tokyo, Japan
    Investigational site
Apr 19, 2022

Parkinson Disease Trial in Tempe (CVN424)

Completed
  • Parkinson Disease
  • Tempe, Arizona
    Celerion
Nov 30, 2022

Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Rabeprazole)

Completed
  • Relapsed or Refractory Lymphoma
  • Austin, Texas
    PPD Austin
Oct 5, 2022

Diabetic Nephropathy Trial in Changchun (HEC73077 tablets, HEC73077 tablets)

Recruiting
  • Diabetic Nephropathy
  • HEC73077 tablets
  • HEC73077 placebo tablets
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Aug 5, 2022

Diabetes, Type 2 Trial in Seoul (HGR4113, Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Nov 30, 2022

Pruritus Trial (linerixibat)

Not yet recruiting
  • Pruritus
  • (no location specified)
Jun 22, 2022

HIV Trial (Cabotegravir IR Formulation (reference), Cabotegravir DT Formulation (test 1), Cabotegravir DT Formulation (test 2))

Not yet recruiting
  • HIV Infections
  • Cabotegravir IR Formulation (reference)
  • +2 more
  • (no location specified)
Mar 8, 2023

Healthy Volunteers Trial in Lincoln (Maribavir)

Completed
  • Healthy Volunteers
  • Lincoln, Nebraska
    Celerion
Aug 8, 2022

Cognitive Disorders Trial in Leuven (SDI-118, Placebo)

Completed
  • Cognitive Disorders
  • Leuven, Belgium
    Centre for Clinical Pharmacology, UZ Leuven
Aug 2, 2022

Solid Tumor Trial in Wuhu (Fuzuloparib)

Active, not recruiting
  • Solid Tumor
  • Wuhu, Anhui, China
    Wannan Medical College Yijishan Hospital
Jul 28, 2022